Search News
| 3.48 BATS BZX Real-Time Price As of 11:07am ET |  +0.18 / +5.45%Today’s Change | 3.22 Today|||52-Week Range 9.40 | -24.68% Year-to-Date |
| Biotech Stock Roundup: Spectrum Up, Incyte Down, AveXis to Merge with Novartis Apr 11 / Zacks.com - Paid Partner Content |
| Previous close | 3.30 |
| Today’s open | 3.30 |
| Day’s range | 3.30 - 3.51 |
| Volume | 9,677 |
| Average volume (3 months) | 645,100 |
| Market cap | $218.5M |
| Earnings growth (last year) | +53.44% |
| Earnings growth (this year) | -10.25% |
| Earnings growth (next 5 years) | +74.00% |
| Revenue growth (last year) | +4,327.38% |
| P/E ratio | NM |
| Price/Sales | 3.73 |
| Price/Book | 7.80 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDSIBioDelivery Sciences... | 0.00 | 0.00% |
| ALRNAileron Therapeutics... | +0.42 | +7.84% |
| ADMPAdamis Pharmaceutica... | +0.03 | +0.70% |
| OCXOncoCyte Corp | -0.18 | -7.45% |
| Next reporting date | May 3, 2018 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $35.4M |
| Annual profit (last year) | -$17.4M |
| Net profit margin | -49.17% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven J. Mento |
Executive VP, Chief Operating & Financial Officer Keith W. Marshall |
Corporate headquarters San Diego, California |
